KURIAKOSE EMIL (Chief Medical Officer) sold 7.6% of their position (4.48K shares) of TERNS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $25.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/6/2025ACC: 0001562180-25-000221
Officer· Chief Medical Officer
Since Mar 2024
-4.48K
Net shares
Net seller
$25.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.48K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.48K
Price / share
$5.71
Trade value
$25.61K
% of position
7.6%
1/2/2025
58.75K→54.27K
Total
Net shares
−4.48K
Net value
-$25.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2025 | S · Sale | −4.48K | $5.71 | $25.61K | 7.6% | 58.75K | 54.27K |
| Total | −4.48K | -$25.61K | ||||||
Derivative Transactions0
No derivative transactions reported